Researchers Identify Potential New Class of Drugs to Treat Blood and Bone Marrow Cancers

First published in the latest edition of Blood Cancer Discovery, the decade long research which reports that a new pharmacological strategy to preferentially target and eliminate leukemia cells with TET2 mutations, was carried out by Jaroslaw Maciejewski and his collaborator Babal Kant Jha from the Cleveland Clinic Department of Translational Hematology & Oncology Research.

from Top World News- News18.com https://ift.tt/2KzykU2